- Sections
- C - Chimie; métallurgie
- C12N - Micro-organismes ou enzymes; compositions les contenant; culture ou conservation de micro-organismes; techniques de mutation ou de génétique; milieux de culture
- C12N 5/16 - Cellules animales
Détention brevets de la classe C12N 5/16
Brevets de cette classe: 1349
Historique des publications depuis 10 ans
80
|
77
|
94
|
105
|
109
|
87
|
68
|
58
|
43
|
13
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Regents of the University of California | 18943 |
19 |
Regeneron Pharmaceuticals, Inc. | 3650 |
18 |
F. Hoffmann-La Roche AG | 7958 |
14 |
The University of British Columbia | 1432 |
12 |
Amgen Inc. | 3779 |
11 |
The Trustees of the University of Pennsylvania | 4122 |
11 |
Dana-Farber Cancer Institute, Inc. | 2455 |
11 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
10 |
Crystal Bioscience Inc. | 81 |
10 |
Genentech, Inc. | 3742 |
9 |
Board of Regents, The University of Texas System | 5370 |
9 |
Abbvie Inc. | 1808 |
9 |
Arius Research Inc. | 25 |
9 |
Novartis AG | 11238 |
8 |
CRISPR Therapeutics AG | 361 |
8 |
Centre National de La Recherche Scientifique | 9632 |
7 |
The Trustees of Columbia University in the City of New York | 3440 |
7 |
The Board of Trustees of the University of Illinois | 2623 |
7 |
Takeda Pharmaceutical Company Limited | 2961 |
7 |
E. R. Squibb & Sons, L.L.C. | 130 |
7 |
Autres propriétaires | 1146 |